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Dear Editor:
We were interested to see that the last issue of 
the journal was a monograph dedicated to food 
and eating and their connection to both health 
and public policy. In particular, Freidin’s ar-
ticle(1) caught our attention. The article makes 
mention of the views regarding food practices 
and health of a part of the population, among 
which salt consumption is included. Such 
practices are described as generally reflecting 
the “dominant food discourse” and national 
health policies. The work also mentions the 
uncertainty and suspicion generated by the 
frequent changes in the medical-scientific 
discourse.
In this letter we do not intend to cast 
doubt upon the importance of campaigns di-
rected at reducing salt intake, but rather to 
take this opportunity to put into perspective 
the justifications of the specific recommended 
values in the light of recent publications. 
What do the official 
recommendationS Say?
The World Health Organization (WHO) 
recommends a sodium intake of less than 
2,000 mg/day for all adults,(2) which equates 
to 5,000 mg/day of sodium chloride (to 
avoid confusion, this text will express intake 
in terms of mg/day of the sodium element). 
The Guías alimentarias para la población 
argentina [Food guidelines for the Argentine 
population] for 2016 propose the same upper 
limit.(3) The US recommendation for 2015 ad-
vises consuming no more than 2,300 mg/day 
of sodium in the general population, and a 
reduction to 1,500 mg/day in those with pre-
hypertension or hypertension.(4)
However, real sodium consumption 
differs greatly from these recommendations. 
In Argentina, the local participants in the 
observational studies INTERSALT and PURE 
showed average values of 3,600 and 4,660 
mg/day respectively.(5,6) The most recent 
measurement carried out in 2011-2012 by 
the program Menos Sal, Más Vida [Less Salt, 
More Life] showed an average sodium intake 
of 4,500 mg/day.(7) In the US, only 9% of the 
population complies with the official recom-
mendation for the general population and 
only 0,6% meet the value suggested for those 
with prehypertension or hypertension.(8)
What are the recommendationS 
baSed on?
The justification for these recommenda-
tions utilizes two well-established bodies of 
evidence indicating that, on one hand, greater 
sodium intake is associated with greater prev-
alence of arterial hypertension, and on the 
other, that hypertension is a known risk factor 
for coronary and cerebrovascular disease. 
Therefore, it seems natural to conclude that 
reducing the amount of dietary salt would 
lead to a reduction in vascular events, but the 
latter has not been as easy to demonstrate. 
Let us review the existing evidence.
Salt consumption varies greatly among 
cultures, and arterial hypertension prevalence 
follows this variation. The INTERSALT study 
evaluated sodium intake in 52 countries and 
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found median values as extreme as 5 mg/day 
in the Yanomamo people of Brazil and 5,600 
mg/day in the north of China.(5) Mean blood 
pressure varies similarly, with an increase of 
3 to 6 mmHg in systolic blood pressure and 
0 to 3 mmHg in diastolic blood pressure for 
every additional 2,300 mg/day of sodium 
consumed. Populations with an intake of less 
than 1,000 mg/day show practically no ar-
terial hypertension. In addition, the results of 
the Framingham study have identified arterial 
hypertension as a primary risk factor for cor-
onary and cerebrovascular disease.(9)
With respect to the impact of interven-
tions to reduce salt intake in  clinically rel-
evant  outcomes, an extensive WHO review 
confirmed the expected decrease in blood 
pressure(10) but found only two clinical trials 
that had explored the effect on vascular 
events – and these did not show a signif-
icant reduction when compared to the usual 
diet.(11) Regarding the numerous observa-
tional studies that evaluate the relationship 
between sodium intake and cardiovascular 
events, a systematic review that gathered in-
dividual data on more than 133,000 people 
from 49 countries showed a “J-shaped” re-
lationship: intake both above 7,000 mg/day 
and below 3,000 mg/day are associated with 
greater all-cause mortality and non-fatal car-
diovascular events.(12) Another meta-analysis 
showed similar results.(13)
Reflecting this uncertainty, a 2013 report 
carried out by the prestigious US Institute of 
Medicine concluded(14):
The committee found that the evi-
dence from studies on direct health 
outcomes was insufficient and incon-
sistent regarding an association between 
sodium intake below 2,300 mg per day 
and benefit or risk of CVD outcomes 
(including stroke and CVD mortality) 
or all-cause mortality in the general US 
population.
The controversy is thus established: of-
ficial bodies recommend an ideal sodium 
intake whose efficacy is not appropriately 
studied in clinical trials and that is associated 
with increased mortality and non-fatal out-
comes in observational studies. Is it possible 
to reconcile these views?
an unreSolved controverSy
Defenders of the policy of substantially 
reducing sodium intake in the general popu-
lation argue that the observational studies that 
describe the “J-shaped” relationship between 
dietary sodium  and vascular events could be 
wrong, because they have important method-
ological flaws,(15) such as:
   measurement imprecision, given that sodium 
intake is estimated through questionnaires 
(in some cases), or through a single mea-
surement of the urine Na/creatinine ratio;
  the possibility of inverse causality, that is, 
an individual could have a smaller sodium 
intake precisely because they were diag-
nosed with cardiovascular disease, and not 
the opposite; and
  the inappropriateness of pooling results 
within a meta-analysis given the different 
methods of measuring exposure and out-
comes, in addition to the different cutoff 
limits established in categorizing sodium 
levels within the diet.
These same defenders recognize, how-
ever, that clinical studies of dietary sodium 
restriction in  people with hypertension have 
not had enough power to demonstrate a re-
duction in cardiovascular disease; they also 
highlight the difficulties in organizing and 
funding a study that could show the bene-
fits in the low-risk population, which would 
require that a randomized sample of 30,000 
people be followed over 5 years.(15)
On the other hand, the researchers who 
described the cardiovascular risks of low 
sodium intake in the extensive international 
PURE study showed that the observed effect 
persists after excluding from the analysis all 
individuals with prior cardiovascular disease, 
use of hypertension drugs, or cancer; after ex-
cluding the episodes that occurred in the first 
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two years of the study follow-up; and after ad-
justing for all the measured confounders.(16) 
This makes inverse causation or the existence 
of confounders improbable as an explanation 
of the findings.
The plausibility of the harmful effects of a 
sodium intake under 2,300 mg/day could be 
explained by the activation of renal sodium 
retention mechanisms, including the re-
nin-angiotensin-aldosterone system and the 
sympathetic system, in addition to producing 
unfavorable lipid changes and increased in-
sulin resistance.(8)
Considering the totality of the results re-
viewed, we can conclude that the controversy 
is not resolved. The detection of a harmful 
effect of low sodium intake in observational 
studies merits questioning the justifications 
behind the universal recommendation of 
limiting sodium to less than 2,000 or 2,300 
mg/day, but it is not possible to reach a defin-
itive conclusion until clinical trials with suffi-
cient strength to address this issue are carried 
out.(14,17,18,19)
hoW Should public policy be 
oriented in the meantime?
Reaching compliance with official guide-
lines in the entire population would imply 
modifications in dietary habits of a magnitude 
that cannot be justified in the absence of solid 
evidence. The disparity between real sodium 
intake and the recommendations, as well as 
the acknowledged difficulty in achieving sus-
tained habit modifications at the population 
level, generate a very particular situation: 
the proposed goal is so strict that there is no 
realistic hope of reaching it, and therefore, 
the debate regarding the eventual harm that 
could be caused were the recommendation 
to be complied with becomes in part an aca-
demic exercise.
Ideally public policy would recognize this 
uncertainty and propose a less ambitious but 
more realistic reduction in the population’s 
sodium consumption, enough to achieve a 
significant reduction in blood pressure and 
the vascular events associated with excessive 
consumption. In this way, it has been esti-
mated that in Argentina a reduction of 1,200 
mg/day in the average sodium intake (from 
4,500 to 3,300 mg/day) would decrease 
heart attacks and strokes by 20% and lower 
all-cause mortality by 6,4%.(20) Another publi-
cation recently showed the cost-effectiveness 
of reducing the population’s sodium intake 
by 10% to 30% in relative terms, or by 500 
to 1,500 mg/day in absolute terms,(21) which 
would achieve clear benefits even though 
the resulting sodium intake would remain far 
above the recommendations in question.
A policy adapted to the available ev-
idence would propose a moderate goal, 
achievable in the general population, and 
would avoid the severity of such an extreme 
objective that lacks scientific foundation.
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